|
인쇄하기
취소
|
Large packaged drugs to investigate its quality.
Published: 2003-12-03 06:57:00
Updated: 2003-12-03 06:57:00
The Korea Pharmaceutical Association (KPA) is going to request an overall investigation over the large packaged drugs that were suspected of its quality.
The Illicit and Substandard Drug Report Center affiliated to the KPA recommended to the government authority on Dec. 1 that Hanwha's "Livial tablet" be cancelled its registration from the KFDA with other appropriate administrative measure...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.